The Ibn Sina Pharmaceutical Industry's profit grew marginally in the second quarter of fiscal year 2024-25. The company's ...

During the October-December quarter, Renata PLC reported a consolidated net profit of Tk64.72 crore, with earnings per share (EPS) at Tk5.64. This marked a significant decline from Tk88 crore in net ...

Becton, Dickinson and Company (NYSE:BDX), a leading player in the medical technology sector with a market capitalization of ...

BD. (BDX), a global medical technology company, and Biosero, a developer of laboratory automation solutions, Thursday announced that ...

After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has ...

The deal, aimed at expanding quality healthcare, was signed with AKS Khan Pharmaceuticals, said a press release ...

In a recent transaction, Shan David, Executive Vice President and Chief ISC Officer at Becton Dickinson & Co (NYSE:BDX), sold ...

Becton, Dickinson and Co. (BD) is investing in its U.S. manufacturing network to add capacity for critical medical devices, ...

Becton, Dickinson's stock momentum is improving, but geopolitical risks and global headwinds warrant caution. Click here to ...

BD invested $10 million last year to increase manufacturing capacity. The recent expansion has created more than 200 jobs.

Becton, Dickinson and Co. is increasing its U.S. manufacturing capacity for essential medical devices, including syringes, needles and IV catheters.